Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
Search
EARLY STAGE
 
My Lists

Cerimon Pharmaceuticals

701 Gateway Blvd. Suite 100
South San Francisco, CA 94080
USA
650 827 4000
Website Company Summary Management Team
Team

Management: Daniel Levitt (EVP R&D)
Outside board: Anspert Gadicke (MPM Capital)Paul J. Hastings (OncoMed Pharmaceuticals President/CEO) Robert J. Adelman (OrbiMed)Denise Pollard-Knight (Nomura Phase4 Ventures) Vaughn Kailian (MPM Capital)James S. Shannon (Novartis Pharma Former Head of Global Development Initiatives)
Company

Business description: Cerimon Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in the development and commercialization of therapeutics in the areas of autoimmune disease, inflammation, and pain. The company's name is derived from a character in Shakespeare's Pericles. Cerimon was a kindly physician who healed miraculously. The Cerimon name symbolizes the company's desire to provide patients with innovative therapeutics to address today's unmet medical needs.
Capital

Rounds: 1
Recent fundings: Oct 2005
Capital raised: 70.0M
Last Round: 70.0M
Ownership: Private  
VCs include: MPM CapitalOrbiMed;  Nomura Phase4 Ventures

Last Tweets


 

Last Mentions


Overview
Record updated: Sep 2010
Sector: Biotech
Rounds: 1
Recent fundings: Oct 2005
Capital raised: 70.0M
Last Round: 70.0M
Ownership: Private